Skingenix, Inc.

Dermal Regeneration Technologies

Skip to content

Home
About
News
Investors
Careers
Contact

Home

Innovation in Medical Research
Cutting Edge Regenerative Technology
Breakthrough in Medical Products
Commitment to Find Advanced Therapies

Introduction

Regenerative medicine and therapy is an innovative concept described through a new research field and represents a unique approach towards the goal of regenerating functional tissues and organs. The term “regeneration” implies that the human body can possibly be stimulated to regenerate by itself through the use of its own potential but this stimulation requires appropriate trigger or promotion factor as well as an appropriate physiological environment.

Skingenix, Inc. is currently pursuing a number of indications under an Investigational New Drug Application (IND) in the USA. A Phase II randomized and controlled clinical trial to assess the safety and efficacy of the investigational product in patients with Diabetic Foot Ulcers has recently been successfully completed in the USA.

Preliminary non-clinical and clinical study results indicate that this investigational product may promote regenerative cells to heal the wounds.

Recent Posts

Skingenix, Inc. announces treatment of the first patient with investigational drug, MW-III in adult patients with Second-Degree Thermal Burns in USA.
Skingenix, Inc. announces successful completion of a Phase II, Randomized, Controlled, Multi-Center Study
Skingenix, Inc. announces treatment of the first patient with the investigational product in patients with Diabetic Foot Ulcers in USA.
Skingenix, Inc. announces completion of two pilot clinical studies with the investigational product in patients with Venous Leg Ulcers and Diabetic Foot Ulcers in USA.

Copyright © 2012 - 2024 SKINGENIXUSA.COM. All Rights Reserved